Tag: breast cancer

FDA Grants Genentech’s New Med for Breast Cancer

South San Francisco, CA   March 8, 2019 Genentech Press Release FDA Grants Genentech’s Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer — This Tecentriq combination is the first cancer immunotherapy regimen approved for breast…

Genentech’s Latest Effort to Combat Breast Cancer

South San Francisco, CA   October 16, 2018 Press Release Genentech’s Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment — Phase III KATHERINE study shows Kadcyla® significantly improved invasive…